Literature DB >> 16361278

Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks.

Fritz Diekmann, Josep M Campistol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16361278     DOI： 10.1093/ndt/gfi336

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  15 in total

1.  Early experience with conversion to sirolimus in a pediatric renal transplant population.

Authors:  Harley R Powell; Tonya Kara; Colin L Jones
Journal:  Pediatr Nephrol       Date:  2007-08-02       Impact factor: 3.714

2.  Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.

Authors:  Tangli Xiao; Xu Guan; Ling Nie; Song Wang; Lei Sun; Ting He; Yunjian Huang; Jingbo Zhang; Ke Yang; Junping Wang; Jinghong Zhao
Journal:  Mol Cell Biochem       Date:  2014-05-22       Impact factor: 3.396

3.  The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Byung Ha Chung; Bo-Mi Kim; Mi-La Cho; Chul Woo Yang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

4.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.

Authors:  Ken Inoki; Hiroyuki Mori; Junying Wang; Tsukasa Suzuki; SungKi Hong; Sei Yoshida; Simone M Blattner; Tsuneo Ikenoue; Markus A Rüegg; Michael N Hall; David J Kwiatkowski; Maria P Rastaldi; Tobias B Huber; Matthias Kretzler; Lawrence B Holzman; Roger C Wiggins; Kun-Liang Guan
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

Review 5.  Treatment of severe lupus nephritis: the new horizon.

Authors:  Tak Mao Chan
Journal:  Nat Rev Nephrol       Date:  2014-11-25       Impact factor: 28.314

Review 6.  Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.

Authors:  Ka Wai Mok; Dolores D Mruk; C Yan Cheng
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

7.  Conversion to sirolimus of patients with chronic allograft nephropathy--a retrospective analysis of outcome and influencing factors.

Authors:  Oliver Witzke; Ondrej Viklicky; Tobias R Türk; Jens Lutz; Benjamin Wilde; Isabel Willenberg; Stefan Vitko; Uwe Heemann
Journal:  Langenbecks Arch Surg       Date:  2008-11-20       Impact factor: 3.445

Review 8.  Sirolimus-associated proteinuria and renal dysfunction.

Authors:  Gopala K Rangan
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

Review 9.  Nutrient sensing, autophagy, and diabetic nephropathy.

Authors:  Shinji Kume; Merlin C Thomas; Daisuke Koya
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

10.  Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients.

Authors:  Kanecia O Zimmerman; Huali Wu; Rachel Greenberg; Jeffrey T Guptill; Kevin Hill; Uptal D Patel; Lawrence Ku; Daniel Gonzalez; Christoph Hornik; Wenlei Jiang; Nan Zheng; Chiara Melloni; Michael Cohen-Wolkowiez
Journal:  Ther Drug Monit       Date:  2016-10       Impact factor: 3.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.